 Viridian Therapeutics, Inc. NASDAQ:VRDN Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants John Jordan - VP, Investor Relations and Corporate Communications Jonathan Violin - CEO, President Director Kristian Humer - CFO, Chief Business Officer, Principal Financial Officer Principal Accounting Officer Conference Call Participants Christopher Howerton - Jefferies Thomas Smith - SVB Leerink Laura Chico - Wedbush Securities Rami Katkhuda - LifeSci Capital Jason Butler - JMP Securities Operator Welcome to the Viridian Therapeutics First Quarter 2022 Conference Call. Operator Instructions. 